The Board of Directors and the CEO of Emotra AB hereby present the interim report for the first nine months of 2019. 191024 Interim report Jan-Sept 2019
Emotra AB Interim report Jan – Sept 2019
read more
News archive
Emotra: Negotiations about research and technology collaborations
Emotra AB (“Emotra”) is presently negotiating about research collaborations on EDOR® Test with prominent university hospitals in several European countries. 190925 - Emotra -Newsletter - Research collaborations
Emotra AB (publ) Interim report January 1 – June 30, 2019
The Board and CEO of Emotra AB (publ) hereby present the interim report for the first six months of 2019. 190823 Interim report Jan-June 2019
Emotra: New focus areas and more research collaborations
Emotra AB (“Emotra”) has had an eventful spring. New data which show that EDOR® can identify patients with an increased risk of depressive relapse are turning out to be more and more important. Emotra is now increasingly engaged in discussions with psychiatric...
Emotra AB (publ) Interim report January 1 – March 31, 2019
The Board and CEO of Emotra AB (publ) hereby present the interim report for the first quarter 2019. 190515 Interim report Jan-March 2019
Communiqué from the Annual General Meeting of EMOTRA AB (publ)
The Annual General Meeting of EMOTRA AB (publ) was held today, May 15, 2019. The resolutions, summarised below, were all adopted with the necessary majority. 190515 - Emotra- PM - Communiqué from AGM
EDOR® Test Identifies Patients with a Higher Risk of Depression Relapse
Emotra has previously announced that new research results have indicated new application areas for Emotra’s method, EDOR. These areas open new possibilities for widening the method’s use in clinical practice. We can now reveal that the application in question concerns...
Emotra is granted a patent in the USA
The US will be one of Emotra’s priority markets in the future. We have earlier announced that the Company has applied for patents in the EU, USA, Canada and Japan and patents have been granted in Sweden and Japan. The US patent office has now informed us that Emotra’s...
Documents for the Annual General Meeting now available
Emotra AB (publ) (“Emotra”) today announces that the Company’s Annual Report for the financial year 2018, as well as other documents required for the Annual General Meeting are available from the Company’s web site (www.emotra.se) as of today, and are also provided...
Notice of Annual General Meeting of shareholders in Emotra AB (publ)
Notice is hereby given that the Annual General Meeting of shareholders in Emotra AB (publ), 556612-1579, will be held at 11:00 am on Wednesday May 15, 2019, at the restaurant John Scott´s Pub at 15, Kungsportsavenyn in Göteborg, Sweden. 190415 - Emotra- PM -...